Ivermectin Versus Albendazole for Chronic Strongyloidiasis
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
A prospective controlled trial to compare the efficacy and safety of 7-day albendazole,
single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic
strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.